As reported in many studies, BRCA1 mutations are responsible for a large increase in the lifetime risk of breast and ovarian cancers [43], and plays a role in targeting prophylactic interventions and treatment [44,45]. The gene discussed is BRCA1; the disease is ovarian cancer.